The eligibility study reported by Fierce Healthcare underscores how large this overlap is: the semaglutide-eligible population it identified included tens of millions of adults covered by Medicare and Medicaid, many of whom qualify through diabetes or cardiovascular indications rather than weight criteria alone
Laboratory studies frequently explore receptor pathway interactions, peptide-mediated communication between endocrine systems, and the molecular signaling mechanisms that influence cellular metabolic processes
However, the boxed warning regarding thyroid C-cell tumors observed in rodent studies remains relevant, and thorough patient screening is essential before initiating therapy
triggering neuroinflammation through microglial activation and chronic inflammatory responses
Over 600 active trials currently test these medications across multiple medical conditions
Certain skin-related symptoms during GLP-1 treatment require prompt medical attention